Genzyme Corporation v. Novartis Gene Therapies, Inc.
Summary
Genzyme sues Novartis for allegedly infringing patents related to gene therapy treatments.
Summary generated by AI from public docket data. Verify against the original filing before relying on it.
Coverage vs reality meter
Counsel of record
- Independent counselAmanda K. Antons, Brian M. Goldberg, Daniel R. Roberts +8 more
- Wilks Law, LLCDavid E. Wilks, Donald C. Vavala , III, Scott B. Czerwonka
- Independent counselCora R. Holt, Jeffrey D. Smyth, John D. Livingstone +1 more
- McCarter & English, LLPAlexandra M. Joyce, Daniel M. Silver
- Court
- DED
- Docket no.
- 1:23-cv-00554
- Nature of suit
- Patent
- Filed
- 2023-05-19
- Last filing
- 2024-02-14
Cause
35:1 Patent Infringement
Entities in this case
Parties
Aventis Inc. (plaintiff) Genzyme Corporation (plaintiff) Novartis Pharmaceuticals Corporation (defendant) Novartis Gene Therapies, Inc. (defendant)
Docket entries
- 2024-02-02
Oral Order
- 2024-01-11
1 - Terminate Hearings AND Oral Order AND ~Util - Set Deadlines
- 2023-12-06
SO ORDERED
- 2023-07-25
SO ORDERED
- 2023-07-21
SO ORDERED
- 2023-07-19
SO ORDERED
- 2023-07-14
Add Attorneys - PHV only
- 2023-07-10
1 - Terminate Hearings AND Oral Order
- 2023-06-29
Add Attorneys - PHV only
- 2023-06-23
- CORRECTING ENTRY
- 2023-06-23
CORRECTING ENTRY: The docket text for the So Ordered entry filed on 6/22/2023, has been amended to reflect a ruling on D.I. 25 as well. (nms)
- 2023-06-22
SO ORDERED, re 24 MOTION for Pro Hac Vice Appearance of Attorney Pejmon Pashai, 21 MOTION for Pro Hac Vice Appearance of Attorney Daniel Roberts, 22 MOTION for Pro Hac Vice Appearance of Attorney Jonathan D.J. Loeb, 23 MOTION for Pro Hac Vice Appearance of Attorney Noah M. Leibowitz,and 25 MOTION for Pro Hac Vice Appearance of Attorney Shyam Shanker. Signed by Judge Richard G. Andrews on 6/22/2023. (nms) Modified on 6/23/2023 (nms).
- 2023-06-22
SO ORDERED
- 2023-06-15
Pro Hac Vice Attorney Katherine A. Helm for Genzyme Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
- 2023-06-15
Pro Hac Vice Attorney M. David Weingarten, PhD, Jeffrey D. Smyth, John D. Livingstone, Cora R. Holt for Novartis Gene Therapies, Inc. and Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
- 2023-06-15
Add Attorneys - PHV only
- 2023-06-14
SO ORDERED
- 2023-06-13
SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney John Livingstone, M. David Weingarten, Ph.D., Cora Holt, and Jeffrey Smyth, filed by Novartis Pharmaceuticals Corporation, Novartis Gene Therapies, Inc.. Signed by Judge Richard G. Andrews on 6/13/2023. (nms)
- 2023-06-13
SO ORDERED
- 2023-05-24
Case Assigned/Reassigned
Docket history from CourtListener/RECAP — most recent first.